Rachel Rene Baber is a Tyler, Texas based nurse practitioner. Active license number of Rachel Rene Baber is 1086582 for Pediatrics in Texas. Her current practice location is 214 E Houston St, Tyler. Patients can reach her at 903-535-9041 or can fax her at 903-533-1747 and her NPI number (Unique professional ID assigned by NPPES) is 1396469839. Rachel Rene Baber has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Rachel Rene Baber speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1396469839
NPI Enumeration Date:
28 Sep, 2022
NPI Last Update On:
21 Nov, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rachel Rene Baber are as mentioned below.
License Number
Specialization
State
Status
1086582
Pediatrics
Texas
Primary
891800
Nurse Practitioner
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Rachel Rene Baber 523 S Fannin Ave, Tyler, Texas
Zip:
75702-8204
Phone Number:
903-535-9041
Patients can reach Rachel Rene Baber at 214 E Houston St, Tyler, Texas or can call to book an appointment on 903-535-9041.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.